CD200/OX2 Antibody [Janelia Fluor® 646]
Novus Biologicals, part of Bio-Techne | Catalog # AF3355J

Conjugate
Catalog #
Key Product Details
Species Reactivity
Mouse, Rat
Applications
Immunohistochemistry, Western Blot
Label
Janelia Fluor 646
Antibody Source
Polyclonal Goat IgG
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
Mouse myeloma cell line NS0-derived recombinant mouse CD200
Gln31-Gly232
Accession # O54901
Gln31-Gly232
Accession # O54901
Specificity
Detects mouse CD200 in direct ELISAs and mouse CD200 and rat CD200 Western blots. In direct ELISAs, approximately 50% cross-reactivity with recombinant human CD200 is observed.
Clonality
Polyclonal
Host
Goat
Isotype
IgG
Applications for CD200/OX2 Antibody [Janelia Fluor® 646]
Application
Recommended Usage
Immunohistochemistry
Optimal dilutions of this antibody should be experimentally determined.
Western Blot
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Antigen Affinity-purified
Formulation
50mM Sodium Borate
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: CD200
Alternate Names
CD200, MOX1, MOX2, MRC, OX-2
Gene Symbol
CD200
Additional CD200 Products
Product Documents for CD200/OX2 Antibody [Janelia Fluor® 646]
Product Specific Notices for CD200/OX2 Antibody [Janelia Fluor® 646]
Sold under license from the Howard Hughes Medical Institute, Janelia Research Campus.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...